Agenda

Return

C. 42

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	October 5, 2021

Contra

Costa

County

Subject:

Purchase Order with Clear Labs, Inc.

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 10/05/2021

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Ori Tzvieli, M.D., 925-608-5267
cc:	Marcy Wilhelm Stephanie Trammell

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: October 5, 2021
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Health Services Director, or designee, to execute a Purchase Order with Clear Labs, Inc., in the amount not to exceed $2,000,000 for the purchase of testing reagents and kits for SARS-CoV-2 and other pandemic virus whole genome sequencing at the Contra Costa County Public Health Laboratory, for the period from September 1, 2021 through August 30, 2022.

FISCAL IMPACT:

Approval of this purchase order will result in annual expenditures of up to $2,000,000 and funded by the United States Center for Disease Control Epidemiology and Laboratory Capacity (ELC) awarded grant, COVID-19 ELC Enhancing Detection Expansion (Strategy 2: Strengthen Laboratory Testing).

BACKGROUND:

This purchase order will consolidate previous purchase orders created throughout the year for Clear Labs, Inc. various laboratory supplies (collection kits, reagents, plastic consumables) requied by the Contra Costa County Public Health Laboratory.

BACKGROUND: (CONT'D)

Whole genome sequencing of the SARS-CoV-2 virus in patient specimens permits determination of circulating variants within Contra Costa County. Identifying variants allows Health Services and the Public Health Department to evaluate whether certain variants are associated with increased transmission or particular patient morbidity outcomes.

CONSEQUENCE OF NEGATIVE ACTION:

If this purchase order is not approved, the Contra Costa Public Health Laboratory will not be able to maintain continuous and uninterrupted ordering of much needed laboratory supplies for genome sequencing.